FindTrial
Sign In

Synergy

DEVICE6 trials

Sponsors

Boston Scientific Corporation, Foundation of Cardiovascular Research and Education Enschede, Nutricia UK Ltd, Tokorozawa Heart Center, National University of Ireland, Galway, Ireland

Conditions

Acute Coronary SyndromeAngina PectorisAngina, UnstableArterial Occlusive DiseasesAtherosclerotic Lesion(s)Cardiovascular DiseasesCoronary Artery DiseaseCoronary Disease

Phase 3

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
CompletedNCT01665053
Boston Scientific CorporationCoronary Artery Disease
Start: 2012-11-30End: 2018-12-22Updated: 2019-01-30
EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
CompletedNCT01787799
Boston Scientific CorporationAtherosclerotic Lesion(s)
Start: 2013-03-31End: 2014-10-31Updated: 2016-03-16

Unknown Phase

Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)
CompletedNCT01674803
Foundation of Cardiovascular Research and Education EnschedeAcute Coronary Syndrome, Angina Pectoris, Angina, Unstable +4
Start: 2012-12-21End: 2020-08-25Updated: 2022-07-20
Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia
CompletedNCT03167697
Nutricia UK LtdHyperphenylalaninaemia, Type I, Phenylketonurias
Start: 2017-05-01End: 2018-12-17Updated: 2019-03-13
A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI
CompletedNCT03440801
Tokorozawa Heart CenterSTEMI - ST Elevation Myocardial Infarction
Start: 2017-07-03End: 2024-09-01Updated: 2025-09-08
Multivessel TALENT
Active, not recruitingNCT04390672
National University of Ireland, Galway, IrelandArterial Occlusive Diseases, Cardiovascular Diseases, Coronary Artery Disease +4
Start: 2020-09-22End: 2026-09-01Target: 1550Updated: 2026-02-27

Related Papers

Low-Density Lipoprotein Cholesterol Levels and Neoatherosclerosis After STEMI: A Secondary Analysis of the CONNECT Randomized Clinical Trial.
2025-12-17
Long-term effect of biodegradable vs. durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
2025-08-017 citations
Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trials.
2025-07-061 citations
Diffuseness of coronary artery disease impacts on immediate hemodynamic and predicted clinical outcomes.
2025-01-171 citations
Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease
Cardiovascular Intervention and Therapeutics2024-12-195 citations
Interim prediction of two-year all-cause mortality in patients with de novo multivessel coronary artery disease undergoing intended multivessel PCI
European Heart Journal2023-11-01
Hemodynamic assessment of pci using ultrasonic flow ratio in multivessel cad
European Heart Journal2023-11-01
Minimum stent area, stent expansion and ultrasonic flow ratio post pci: insights from multivessel talent trial
European Heart Journal2023-11-01
Premature coronary artery disease in all-comers undergoing first PCI
European Heart Journal2023-11-01
First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents
European Heart Journal Acute Cardiovascular Care2023-08-224 citations
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials
Cardiovascular Diagnosis and Therapy2023-08-012 citations
Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
Frontiers in Cardiovascular Medicine2023-06-195 citations
Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
Journal of the American Heart Association2022-11-0829 citations
Clinical outcome up to 2 years after percutaneous coronary intervention in all-comers with concomitant symptomatic peripheral arterial disease: a pooled analysis in 9,204 randomized trial participants
European Heart Journal2022-10-01
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience
Reviews in Cardiovascular Medicine2022-04-085 citations
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials
Cardiovascular Diabetology2021-10-3026 citations
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
EuroIntervention2020-12-0114 citations
Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
Catheterization and Cardiovascular Interventions2020-04-0118 citations
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
2020-04-018 citations
Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
Catheterization and Cardiovascular Interventions2019-10-1712 citations

9 more papers not shown